Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications.
This activity is supported by an independent educational grant from Neurocrine …
Sponsor
This activity is supported by an independent educational grant from Neurocrine …
Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications.
Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications.
The Clinical Conundrum in Managing Preterm Birth: Balancing Historical Trial Results, Society Guidelines, and Clinical Experience with a Contradictory Trial Outcome
Since its approval in 2011, 17-alpha hydroxyprogesterone caproate (17-OHPC, trade name Makena®, AMAG Pharmaceuticals, Inc, Waltham, MA) has been designated the “standard of care “ for treating pregnant patients with a history of spontaneous preterm birth (SPTB) by the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine (SMFM), and the American College of Nurse Midwives (ACNM). Several clinical trials and years of clinical experience have demonstrated its safety and efficacy.
This CME supplement details results of the PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) trial evaluating 17-OHPC in patients with a history of a prior spontaneous singleton preterm delivery.
This activity is supported by an independent educational grant from AMAG Pharma…
Sponsor
This activity is supported by an independent educational grant from AMAG Pharma…
Since its approval in 2011, 17-alpha hydroxyprogesterone caproate (17-OHPC, trade name Makena®, AMAG Pharmaceuticals, Inc, Waltham, MA) has been designated the “standard of care “ for treating pregnant patients with a history of spontaneous preterm birth (SPTB) by the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine (SMFM), and the American College of Nurse Midwives (ACNM). Several clinical trials and years of clinical experience have demonstrated its safety and efficacy.
This CME supplement details results of the PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) trial evaluating 17-OHPC in patients with a history of a prior spontaneous singleton preterm delivery.
To receive CME credit, please read the article and go to www.omniaeducation.com/ptb to access the posttest and evaluation.
Since its approval in 2011, 17-alpha hydroxyprogesterone caproate (17-OHPC, trade name Makena®, AMAG Pharmaceuticals, Inc, Waltham, MA) has been designated the “standard of care “ for treating pregnant patients with a history of spontaneous preterm birth (SPTB) by the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine (SMFM), and the American College of Nurse Midwives (ACNM). Several clinical trials and years of clinical experience have demonstrated its safety and efficacy.
This CME supplement details results of the PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) trial evaluating 17-OHPC in patients with a history of a prior spontaneous singleton preterm delivery.
The Clinical Conundrum in Managing Preterm Birth: Balancing Historical Trial Results, Society Guidelines, and Clinical Experience with a Contradictory Trial Outcome
Display Headline
The Clinical Conundrum in Managing Preterm Birth: Balancing Historical Trial Results, Society Guidelines, and Clinical Experience with a Contradictory Trial Outcome
Reducing Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
This supplement offers the opportunity to earn a total of 1 CME credit.
Credit is awarded for successful completion of the online evaluation at the link below. This link may also be found within the supplement on the first page of the article.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/CVEvents to complete the online post-test and receive your certificate of credit.
Sponsor
This supplement was sponsored by Primary Care Education Consortium and Primary …
Reducing Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
This supplement offers the opportunity to earn a total of 1 CME credit.
Credit is awarded for successful completion of the online evaluation at the link below. This link may also be found within the supplement on the first page of the article.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/CVEvents to complete the online post-test and receive your certificate of credit.
Reducing Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
This supplement offers the opportunity to earn a total of 1 CME credit.
Credit is awarded for successful completion of the online evaluation at the link below. This link may also be found within the supplement on the first page of the article.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/CVEvents to complete the online post-test and receive your certificate of credit.
This supplement includes 4 CME credits (scroll down for more information).
Topics include:
Chronic Kidney Disease in Type 2 Diabetes
Heart Failure in Type 2 Diabetes
Diabetes Management
Naproxen vs Opioids
Statin Selection
Insomnia in Alzheimer's Disease
Cluster Headache
Irritable Bowel Syndrome
This supplement offers the opportunity to earn a total of 4 CME credits.
Credit is awarded for scucesful completion of the online evaluations at the links below. These links may also be found within the supplement on the first page of each article.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/DKD to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/DM to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/insomnia to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/IBSD to complete the online post-test and receive your certificate of credit.
Sponsor
This supplement was sponsored by Primary Care Education Consortium and Primary …
This supplement includes 4 CME credits (scroll down for more information).
Topics include:
Chronic Kidney Disease in Type 2 Diabetes
Heart Failure in Type 2 Diabetes
Diabetes Management
Naproxen vs Opioids
Statin Selection
Insomnia in Alzheimer's Disease
Cluster Headache
Irritable Bowel Syndrome
This supplement offers the opportunity to earn a total of 4 CME credits.
Credit is awarded for scucesful completion of the online evaluations at the links below. These links may also be found within the supplement on the first page of each article.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/DKD to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/DM to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/insomnia to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/IBSD to complete the online post-test and receive your certificate of credit.
This supplement includes 4 CME credits (scroll down for more information).
Topics include:
Chronic Kidney Disease in Type 2 Diabetes
Heart Failure in Type 2 Diabetes
Diabetes Management
Naproxen vs Opioids
Statin Selection
Insomnia in Alzheimer's Disease
Cluster Headache
Irritable Bowel Syndrome
This supplement offers the opportunity to earn a total of 4 CME credits.
Credit is awarded for scucesful completion of the online evaluations at the links below. These links may also be found within the supplement on the first page of each article.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/DKD to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/DM to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/insomnia to complete the online post-test and receive your certificate of credit.
To receive CME credit, please read the journal article and, upon completion, go to www.pceconsortium.org/IBSD to complete the online post-test and receive your certificate of credit.
Bipolar disorder (BD) is a severe, lifelong disorder associated with high rates of nonrecovery, chronicity, and premature mortality. The actionable opportunity for reducing the morbidity and mortality of BD is to address current unmet needs.
This activity is supported by an independent educational grant from Allergan.
Sponsor
This activity is supported by an independent educational grant from Allergan.
Bipolar disorder (BD) is a severe, lifelong disorder associated with high rates of nonrecovery, chronicity, and premature mortality. The actionable opportunity for reducing the morbidity and mortality of BD is to address current unmet needs.
Bipolar disorder (BD) is a severe, lifelong disorder associated with high rates of nonrecovery, chronicity, and premature mortality. The actionable opportunity for reducing the morbidity and mortality of BD is to address current unmet needs.
Diagnosing and Managing Multiple Sclerosis: A Personalized Approach
Multiple sclerosis (MS) is one of the leading causes of disability and many efforts have been implemented to help expediate diagnosis and initiate early, effective treatment. With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of MS, such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis.
METHOD OF PARTICIPATION AND INSTRUCTIONS FOR CREDIT
If you wish to receive acknowledgement for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. In the “Find Post-test/Evaluation by Course” field at the top of the page, search by course ID 14335. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year. If you have questions regarding the receipt of your e-mailed certificate, please contact Postgraduate Intitue for Medicine via e-mail at [email protected].
This activity is supported by an independent educational grant from Genentech.
Sponsor
This activity is supported by an independent educational grant from Genentech.
Multiple sclerosis (MS) is one of the leading causes of disability and many efforts have been implemented to help expediate diagnosis and initiate early, effective treatment. With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of MS, such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis.
METHOD OF PARTICIPATION AND INSTRUCTIONS FOR CREDIT
If you wish to receive acknowledgement for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. In the “Find Post-test/Evaluation by Course” field at the top of the page, search by course ID 14335. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year. If you have questions regarding the receipt of your e-mailed certificate, please contact Postgraduate Intitue for Medicine via e-mail at [email protected].
Multiple sclerosis (MS) is one of the leading causes of disability and many efforts have been implemented to help expediate diagnosis and initiate early, effective treatment. With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of MS, such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis.
METHOD OF PARTICIPATION AND INSTRUCTIONS FOR CREDIT
If you wish to receive acknowledgement for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. In the “Find Post-test/Evaluation by Course” field at the top of the page, search by course ID 14335. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year. If you have questions regarding the receipt of your e-mailed certificate, please contact Postgraduate Intitue for Medicine via e-mail at [email protected].
Major Depressive Disorder: Unmet Needs and Innovative Treatments
Many of the unmet needs in major depressive disorder (MDD) are modifiable, including improving diagnostic accuracy and offering treatments with faster onset of action, treatments with greater overall efficacy, and treatments that can improve patient functioning.
This activity is supported by an independent educational grant from Allergan.
Sponsor
This activity is supported by an independent educational grant from Allergan.
Many of the unmet needs in major depressive disorder (MDD) are modifiable, including improving diagnostic accuracy and offering treatments with faster onset of action, treatments with greater overall efficacy, and treatments that can improve patient functioning.
Many of the unmet needs in major depressive disorder (MDD) are modifiable, including improving diagnostic accuracy and offering treatments with faster onset of action, treatments with greater overall efficacy, and treatments that can improve patient functioning.
A majority of patients with psoriasis are undertreated. In recent years, however, new formulations of topical medications for psoriasis have been introduced, with the goal of enhancing penetration, efficacy, and patient acceptance. Along with new systemic therapies, these treatments allow for more aggressive goals for disease clearance.
Topical medications can be used as monotherapy but combining topical agents can increase efficacy and may allow for use of lower doses with fewer adverse events. Fixed-dose combination treatments combine active ingredients in one vehicle and may improve patient adherence and acceptance by simplifying the treatment regimen.
This supplement provides physicians with education on evidence-based assessment and management of psoriasis, the combination of systemic and topical medications, and strategies for improving patient adherence to treatment regimens.
A majority of patients with psoriasis are undertreated. In recent years, however, new formulations of topical medications for psoriasis have been introduced, with the goal of enhancing penetration, efficacy, and patient acceptance. Along with new systemic therapies, these treatments allow for more aggressive goals for disease clearance.
Topical medications can be used as monotherapy but combining topical agents can increase efficacy and may allow for use of lower doses with fewer adverse events. Fixed-dose combination treatments combine active ingredients in one vehicle and may improve patient adherence and acceptance by simplifying the treatment regimen.
This supplement provides physicians with education on evidence-based assessment and management of psoriasis, the combination of systemic and topical medications, and strategies for improving patient adherence to treatment regimens.
A majority of patients with psoriasis are undertreated. In recent years, however, new formulations of topical medications for psoriasis have been introduced, with the goal of enhancing penetration, efficacy, and patient acceptance. Along with new systemic therapies, these treatments allow for more aggressive goals for disease clearance.
Topical medications can be used as monotherapy but combining topical agents can increase efficacy and may allow for use of lower doses with fewer adverse events. Fixed-dose combination treatments combine active ingredients in one vehicle and may improve patient adherence and acceptance by simplifying the treatment regimen.
This supplement provides physicians with education on evidence-based assessment and management of psoriasis, the combination of systemic and topical medications, and strategies for improving patient adherence to treatment regimens.
